ear-Infrared fluorescence imaging during neck dissection in head and neck cancer patients after peritumoral injection of Indocyanine Green (a feasibility study)

Jules Borde Institute0 个研究点开始时间: 2014年9月25日最近更新: 2016年8月16日

适应症

试验速览

暂无简介。

•- All patients requiring neck dissection with resection of the primary (the decision and the type of neck dissection are preliminary decided during head and neck multidisciplinary oncologic consultation).
•- Informed consent form signed.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 10
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•- Age less than18 years old.
•- Inability to give informed consent.
•- History of allergy or hypersensitivity against the investigational product (its active substance or ingredients), to iodine or to shellfish.
•- Apparent hyperthyroidism, autonomous thyroid adenoma, unifocal, multifocal or disseminated autonomies of the thyroid gland.
•- Documented coronary disease.
•- Advanced renal impairment (creatinine > 1,5mg/dl).
•- During the 2 weeks before the enrolment, concurrent medication which reduces or increases the extinction of ICG (i.e. anticonvulsants, haloperidol and heparin).
•- Pregnancy, breastfeeding

发起方

Jules Borde Institute